- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes Treated With Insulin in Poland
Total 825 results
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus, Type 2 | Diabetic Kidney DiseaseNetherlands
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Brazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, South Africa, Argentina, Canada, Germany, Hungary, Israel, Romania, Slovakia, India, Belgium, France, Puerto Rico
-
National Institute of Diabetes and Digestive and...George Washington UniversityCompletedType 2 DiabetesUnited States
-
PfizerCompletedDiabetic NephropathyUnited States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
Centre for Chronic Disease Control, IndiaAll India Institute of Medical Sciences, New Delhi; Public Health Foundation...CompletedHypertension | Type 2 Diabetes MellitusIndia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
-
University of Warmia and Mazury in OlsztynCompletedHypertension | Obesity | Diabetes Mellitus, Type 2Poland
-
Oregon Health and Science UniversityRecruiting
-
Medical University of WarsawUnknown
-
InteKrin Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Mexico
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Germany, Poland, Argentina, United Kingdom, Mexico
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusUnited States, Hungary, Poland, Romania, Italy, United Kingdom
-
Charite University, Berlin, GermanyUniversity of Hull; IRCCS San Raffaele; Hannover Medical School; Russian Cardiology... and other collaboratorsCompletedHeart Failure | Type 2 Diabetes MellitusGermany, Slovenia, United Kingdom, Italy, Poland, Russian Federation
-
Slotervaart HospitalAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)UnknownType 2 Diabetes Mellitus | Obesity, MorbidNetherlands
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Estonia, Latvia, Mexico
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
-
BayerCompletedDiabetic NephropathiesHong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Canada
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Amsterdam UMC, location VUmcCompletedType 2 Diabetes Mellitus | Congestive Heart FailureNetherlands
-
MetaCure (USA), Inc.CompletedDiabetes Mellitus, Type 2Austria, Germany, Italy, Poland
-
Amsterdam UMC, location VUmcCompleted
-
Bristol-Myers SquibbCompletedDiabetes, Type 2United States, Canada, Mexico, Puerto Rico, Australia, Poland, Taiwan
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czechia, Puerto Rico, Poland, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Oregon Health and Science UniversityCompletedPrimary Health Care | Type II Diabetes | Behavioral HealthUnited States
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, China, Italy, Japan, India, Poland, South Africa, Turkey, Greece, Puerto Rico
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusEstonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
-
TheracosCompletedDiabetes MellitusUnited States
-
Bristol-Myers SquibbCompletedDiabetes Type 2United States, Canada, Korea, Republic of, Australia
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusCanada, United States, Italy, Poland, Puerto Rico
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Leiden University Medical CenterHealth Holland; Dutch Diabetes Research Foundation; IFOM, The FIRC Institute... and other collaboratorsCompletedDiabetes Mellitus, Type 2Netherlands
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
Intarcia TherapeuticsCompletedType 2 DiabetesFinland, United States, Bulgaria, Poland, South Africa, Denmark, Turkey, Slovakia, Germany
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
DiObexTerminatedType 2 DiabetesAustralia, United States, New Zealand
-
The Miriam HospitalRhode Island Hospital; University of Massachusetts, LowellCompletedDiabetes Mellitus, Type 2United States